Drug Profile
Research programme: pain therapeutics - InSitu Biologics
Alternative Names: Sustained release hydrogel with bupivacaine - Insitu BiologicsLatest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator InSitu Biologics
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain